# EVEREST (NCT01120249)

> S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT01120249
- Phase: PHASE3
- Status: COMPLETED
- Sponsor: SWOG Cancer Research Network
- Conditions: Kidney Cancer
- Interventions: everolimus; placebo
- Enrollment: 1545
- Primary outcome: 5-year Recurrence-free Survival (RFS)

## Indexed commentary on EVEREST so far

Podcasts, YouTube videos and X posts we have indexed that name the trial. This is where a report starts, not where it ends: the build searches for more, so finished reports usually cover more than this.

- 3 posts on X

## Order

Focused, $750 at most (a smaller delivered size costs its own price): https://www.erudio.com/contact?report=everest-nct01120249